ACRO Biomedical Co Stock

ACRO Biomedical Co EBITDA per Share

The EBITDA per Share of ACRO Biomedical Co (6748.TWO) as of Aug 5, 2026 is -1.52 TWD. In the previous year, EBITDA per Share was -1.05 TWD — a change of 44.78% (lower).

EBITDA per Share

-1.52TWD

YoY

44.78%

Last updated:

EBITDA per Share of ACRO Biomedical Co is 2026 -1.52 TWD. EBITDA per Share of ACRO Biomedical Co was 2025 -1.05 TWD. It decreases by 44.78% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

EBITDA per Share of ACRO Biomedical Co is -1.52 TWD in 2026.

EBITDA per Share of ACRO Biomedical Co changed from -1.05 TWD to -1.52 TWD, representing a 44.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — ACRO Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ACRO Biomedical Co